United States · Venture startup

Who invested in Memory Pharmaceuticals

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 5 Nov 2026

$41Mraised across 2 rounds since 2005, from 2 sources

$31MVenture$10MVenture
Latest round
Venture, $10MMar 2007
Biggest round
$31MVenture · Sept 2005
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20062007
$31MVenture$10MVenture
First round
Venture, $31M
Sept 2005
Biggest round
$31M
Venture · Sept 2005
Between rounds
18 months
from the last two

The rounds

  1. Mar 2007
    Venture$10M1 new

    Reported by marketwatch.com

  2. Sept 2005
    Venture$31M

    No investor was named in the report.

    Reported by oxbio.com

The exit

ExitBuyerPriceWhen
AcquiredRoche$50MNov 2008

From historical deal records. Wrong? Tell us.

Everyone who backed them

Hercules CapitalVenture debt1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Memory Pharmaceuticals

Who invested in Memory Pharmaceuticals?

Memory Pharmaceuticals's investors include Hercules Capital.

How much has Memory Pharmaceuticals raised?

Memory Pharmaceuticals has raised $41M across 2 rounds since 2005.

When did Memory Pharmaceuticals last raise?

Memory Pharmaceuticals's most recent round was a Venture of $10M in Mar 2007.

What was Memory Pharmaceuticals's biggest round?

Memory Pharmaceuticals's largest round on record is $31M (Venture), in Sept 2005.

Who backed Memory Pharmaceuticals first?

Memory Pharmaceuticals's first round on record, in Mar 2007, was backed by Hercules Capital.

What stage is Memory Pharmaceuticals at?

Memory Pharmaceuticals's latest named round is a Venture, in Mar 2007.

Where is Memory Pharmaceuticals based?

Memory Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.